Ironwood Pharmaceuticals Inc. (IRWD) announced after the bell Monday that it has commenced an underwritten public offering of 10,500,000 shares of its Class A common stock. The stock is now down 0.58 on 27K shares.
Ironwood Pharmaceuticals declined during the first half hour of trade Monday and finished with a loss of 0.56 at $13.83 on above average volume. The stock fell to a 3-month low.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.